Investment Firm
Overview
DermAbiotech develops innovative targeted therapies for acute T cell-mediated inflammatory diseases.
Jan 01, 2015
Seed
Highlights
N/A
Location
Social
N/A
Participant Investors
1
Investor Name |
---|
Eclosion SA |
DermAbiotech raised an undisclosed amount on 2015-01-01 in Seed Round
DermAbiotech develops innovative targeted therapies for acute T cell-mediated inflammatory diseases.
Company Funding History
2
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Jan 01, 2015 | Seed Round - DermAbiotech | 1 | - | undefined |
Feb 02, 2016 | Grant - DermAbiotech | 1 | - | 9.8K |
Recent Activity
There is no recent news or activity for this profile.